Oscar Health is trading 5.78% higher in pre-market at $34.28 on November 4, with no confirmed catalyst identified in available search results.
- On November 3, shares gained 4.55% to $32.41.
- Oscar Health is scheduled to report third-quarter results before the market opens on November 5; analystsβ consensus forecast is a loss of $0.11 per share.
- The upcoming report is relevant context, but available evidence does not establish it as the reason for the pre-market move.